• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.

作者信息

Choi Myung-Jin, Ko Kwan Soo

机构信息

Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon 440-746, Korea.

出版信息

J Antimicrob Chemother. 2014 Jan;69(1):275-7. doi: 10.1093/jac/dkt315. Epub 2013 Aug 29.

DOI:10.1093/jac/dkt315
PMID:23997018
Abstract
摘要

相似文献

1
Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.多黏菌素对鲍曼不动杆菌、铜绿假单胞菌和肺炎克雷伯菌临床分离株的突变预防浓度。
J Antimicrob Chemother. 2014 Jan;69(1):275-7. doi: 10.1093/jac/dkt315. Epub 2013 Aug 29.
2
Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates.黏菌素与其他抗菌药物联合使用对鲍曼不动杆菌、肺炎克雷伯菌和铜绿假单胞菌临床分离株的突变预防浓度。
Int J Antimicrob Agents. 2014 Nov;44(5):475-6. doi: 10.1016/j.ijantimicag.2014.07.015.
3
In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.黏菌素对生物被膜相关铜绿假单胞菌和鲍曼不动杆菌的体外杀菌活性。
J Hosp Infect. 2009 Aug;72(4):368-70. doi: 10.1016/j.jhin.2009.03.013. Epub 2009 May 13.
4
Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients.泛耐药肺炎克雷伯菌、铜绿假单胞菌和鲍曼不动杆菌感染：28例患者的特征及转归
Int J Antimicrob Agents. 2008 Nov;32(5):450-4. doi: 10.1016/j.ijantimicag.2008.05.016. Epub 2008 Sep 2.
5
Epidemiology and antibiotic resistance in a large Italian teaching hospital.一家大型意大利教学医院的流行病学与抗生素耐药性
J Chemother. 2015 Jun;27(3):163-6. doi: 10.1179/1973947814Y.0000000183. Epub 2014 Mar 13.
6
Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009.伊朗一所三级大学附属医院重症监护病房患者分离细菌的抗菌药物敏感性监测：2006-2009 年。
Chemotherapy. 2010;56(6):478-84. doi: 10.1159/000321032. Epub 2010 Nov 23.
7
Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.希腊一家医院中肺炎克雷伯菌和鲍曼不动杆菌碳青霉烯类耐药率得到控制，同时黏菌素、庆大霉素和替加环素耐药率上升。
New Microbiol. 2015 Jul;38(3):417-21. Epub 2015 Jul 6.
8
Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.多利培南联合左氧氟沙星、阿米卡星和多黏菌素对铜绿假单胞菌和鲍曼不动杆菌的活性。
Diagn Microbiol Infect Dis. 2010 Jun;67(2):191-7. doi: 10.1016/j.diagmicrobio.2010.01.004. Epub 2010 Mar 24.
9
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
10
In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece.希腊克里特岛一家综合三级医院中耐黏菌素革兰氏阴性菌分离株对多种抗生素的体外敏感性
Clin Infect Dis. 2010 Jun 15;50(12):1689-91. doi: 10.1086/653009.

引用本文的文献

1
No Emergence of Colistin Resistance in the Respiratory Tract of Lung Transplant Patients Treated With Inhaled Colistin.吸入性黏菌素治疗的肺移植患者呼吸道未出现黏菌素耐药情况。
Transpl Int. 2025 Jan 23;37:13545. doi: 10.3389/ti.2024.13545. eCollection 2024.
2
Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomes.紧跟病原体：从铜绿假单胞菌基因组中提高对抗菌药物耐药性的检测和预测。
Genome Med. 2024 Jun 7;16(1):78. doi: 10.1186/s13073-024-01346-z.
3
The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations.
黏菌素在新型β-内酰胺/β-内酰胺酶抑制剂联合应用时代的作用
Antibiotics (Basel). 2022 Feb 20;11(2):277. doi: 10.3390/antibiotics11020277.
4
Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis.全球多粘菌素使用情况：耐药肠杆菌科的出现及其对其遗传基础的影响综述。
FEMS Microbiol Rev. 2022 Feb 9;46(1). doi: 10.1093/femsre/fuab049.
5
Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria.细菌中固有和获得性黏菌素耐药机制的最新进展
Front Med (Lausanne). 2021 Aug 12;8:677720. doi: 10.3389/fmed.2021.677720. eCollection 2021.
6
Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutions.多黏菌素类抗生素：作用模式、耐药性产生及潜在解决方案。
J Biosci. 2021;46(3). doi: 10.1007/s12038-021-00209-8.
7
A Molecular Perspective on Colistin and : Mode of Action, Resistance Genetics, and Phenotypic Susceptibility.关于黏菌素的分子视角：作用模式、耐药遗传学及表型敏感性
Diagnostics (Basel). 2021 Jun 25;11(7):1165. doi: 10.3390/diagnostics11071165.
8
Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapy.多黏菌素 B 联合治疗抑制鲍曼不动杆菌体外耐药性的药效学评价。
Sci Rep. 2021 May 31;11(1):11339. doi: 10.1038/s41598-021-90709-2.
9
Evolution of Colistin Resistance in the Klebsiella pneumoniae Complex Follows Multiple Evolutionary Trajectories with Variable Effects on Fitness and Virulence Characteristics.肺炎克雷伯菌复合体中多粘菌素耐药的进化遵循多种进化轨迹，对其适应性和毒力特征的影响各不相同。
Antimicrob Agents Chemother. 2020 Dec 16;65(1). doi: 10.1128/AAC.01958-20.
10
Overcoming Intrinsic and Acquired Resistance Mechanisms Associated with the Cell Wall of Gram-Negative Bacteria.克服与革兰氏阴性菌细胞壁相关的固有和获得性耐药机制。
Antibiotics (Basel). 2020 Sep 19;9(9):623. doi: 10.3390/antibiotics9090623.